India, May 12 -- As a Professor in the University set up, our days do not usually end when the lectures do. That day had a ...

Progress Software Corporation ( PRGS) Discusses High-Performance Multi-Database Connectivity and WinSQL Features May 7, 2026 1:00 PM EDT ...

Delayed IR access and 14-day logs limit visibility during breaches, increasing attacker dwell time and recovery costs.

Elliptic pointed out that in law enforcement and regulatory investigations, case deconfliction—ensuring different teams do not unknowingly pursue the same ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Jon Gilbert is a Features Writer for Android Police. I've covered Android since 2021, focusing on writing features and guides about Android apps and features that directly affect users. I've attended ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...